The Inflammasome Pathway as a Key Positive Regulator of HIT Pathology – JTH
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn about a recent article by James Michael et al, adding:
”Heparin-Induced Thrombocytopenia Immune Complexes Activate the Inflammasome Pathway in a Complement-Dependent Manner
This study demonstrates that HIT immune complexes trigger NLRP3 inflammasome activation and IL-1β secretion via FcγRIIA and complement-dependent signaling in both human blood and transgenic mouse models, identifying the inflammasome pathway as a key positive regulator of HIT pathology. ”
Title: Heparin-induced thrombocytopenia immune complexes activate the inflammasome pathway in a complement-dependent manner
Authors: James Michael, Sanjay Khandelwal, Antonios Tawk, MD, MSc, Sophia Lazar, Christopher Garren Hester, Trenton G. Hiatt, Gowthami M. Arepally, Steven McKenzie

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?